Monthly Sulfadoxine-Pyrimethamine During Pregnancy Prevents Febrile Respiratory Illnesses: A Secondary Analysis of a Malaria Chemoprevention Trial in Uganda
Open Access
- 13 March 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (4) , ofae143
Abstract
Trials evaluating antimalarials for intermittent preventive treatment in pregnancy (IPTp) have shown that dihydroartemisinin-piperaquine (DP) is a more efficacious antimalarial than sulfadoxine-pyrimethamine (SP); however, SP is associated with higher birthweight, suggesting that SP demonstrates “nonmalarial” effects. Chemoprevention of nonmalarial febrile illnesses (NMFIs) was explored as a possible mechanism. In this secondary analysis, we leveraged data from 654 pregnant Ugandan women without HIV infection who participated in a randomized controlled trial comparing monthly IPTp-SP with IPTp-DP. Women were enrolled between 12 and 20 gestational weeks and followed through delivery. NMFIs were measured by active and passive surveillance and defined by the absence of malaria parasitemia. We quantified associations among IPTp regimens, incident NMFIs, antibiotic prescriptions, and birthweight. Mean “birthweight for gestational age” Z scores were 0.189 points (95% CI, .045–.333) higher in women randomized to IPTp-SP vs IPTp-DP. Women randomized to IPTp-SP had fewer incident NMFIs (incidence rate ratio, 0.74; 95% CI, .58–.95), mainly respiratory NMFIs (incidence rate ratio, 0.69; 95% CI, .48–1.00), vs IPTp-DP. Counterintuitively, respiratory NMFI incidence was positively correlated with birthweight in multigravidae. In total 75% of respiratory NMFIs were treated with antibiotics. Although overall antibiotic prescriptions were similar between arms, for each antibiotic prescribed, “birthweight for gestational age” Z scores increased by 0.038 points (95% CI, .001–.074). Monthly IPTp-SP was associated with reduced respiratory NMFI incidence, revealing a potential nonmalarial mechanism of SP and supporting current World Health Organization recommendations for IPTp-SP, even in areas with high-grade SP resistance. While maternal respiratory NMFIs are known risk factors of lower birthweight, most women in our study were presumptively treated with antibiotics, masking the potential benefit of SP on birthweight mediated through preventing respiratory NMFIs.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01 HD059454)
- National Institute of Allergy and Infectious Diseases (U01 AI155325)
- March of Dimes Foundation
- Bill and Melinda Gates Foundation (OPP1113682)
- Burroughs Wellcome Fund
- ASTMH
This publication has 40 references indexed in Scilit:
- Protective Efficacy and Safety of Three Antimalarial Regimens for the Prevention of Malaria in Young Ugandan Children: A Randomized Controlled TrialPLOS Medicine, 2014
- Systematic Review and Meta-analyses: Fever in Pregnancy and Health Impacts in the OffspringPediatrics, 2014
- On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infectionsExpert Review of Anti-infective Therapy, 2013
- Intermittent Preventive Therapy for Malaria During Pregnancy Using 2 vs 3 or More Doses of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in AfricaJAMA, 2013
- Etiology and Incidence of Viral and Bacterial Acute Respiratory Illness among Older Children and Adults in Rural Western Kenya, 2007–2010PLOS ONE, 2012
- A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized TrialPLOS Medicine, 2011
- Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycinMalaria Journal, 2010
- Upper Respiratory Tract Infection during Pregnancy: Is It Associated with Adverse Perinatal Outcome?American Journal of Perinatology, 2010
- Efficacy and safety of dihydroartemisinin-piperaquineTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 2006